000 | 01928 a2200505 4500 | ||
---|---|---|---|
005 | 20250513154904.0 | ||
264 | 0 | _c19981202 | |
008 | 199812s 0 0 eng d | ||
022 | _a0014-5793 | ||
024 | 7 |
_a10.1016/s0014-5793(98)01269-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorley, S J | |
245 | 0 | 0 |
_aCleavage of translation initiation factor 4G (eIF4G) during anti-Fas IgM-induced apoptosis does not require signalling through the p38 mitogen-activated protein (MAP) kinase. _h[electronic resource] |
260 |
_bFEBS letters _cOct 1998 |
||
300 |
_a41-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmino Acid Chloromethyl Ketones _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aArsenites _xpharmacology |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xmetabolism |
650 | 0 | 4 | _aCaspase Inhibitors |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aEtoposide _xpharmacology |
650 | 0 | 4 | _aEukaryotic Initiation Factor-4E |
650 | 0 | 4 | _aEukaryotic Initiation Factor-4G |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 | _aImmunoglobulin M |
650 | 0 | 4 | _aJurkat Cells |
650 | 0 | 4 | _aMitogen-Activated Protein Kinases |
650 | 0 | 4 |
_aPeptide Initiation Factors _xmetabolism |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 | _aPoly(A)-Binding Proteins |
650 | 0 | 4 |
_aProtein Biosynthesis _xdrug effects |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 |
_aRNA-Binding Proteins _xmetabolism |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aSirolimus _xpharmacology |
650 | 0 | 4 |
_afas Receptor _ximmunology |
650 | 0 | 4 | _ap38 Mitogen-Activated Protein Kinases |
700 | 1 | _aMcKendrick, L | |
700 | 1 | _aBushell, M | |
773 | 0 |
_tFEBS letters _gvol. 438 _gno. 1-2 _gp. 41-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-5793(98)01269-1 _zAvailable from publisher's website |
999 |
_c9786142 _d9786142 |